Clinical Trials Browser

Phase 2 × Metformin × Other × Clear all

NCT01312467 2019-03-05

Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI

Phase 2 Completed

45 enrolled 7 charts

GastrointestinalOther

Obesity, Colorectal Neoplasms, Adenomatous Polyps